Home/Filings/4/0001127602-25-006253
4//SEC Filing

FOSTER JAMES C 4

Accession 0001127602-25-006253

CIK 0001100682other

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 4:41 PM ET

Size

10.3 KB

Accession

0001127602-25-006253

Insider Transaction Report

Form 4
Period: 2025-02-20
FOSTER JAMES C
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2025-02-20$165.01/sh+6,075$1,002,436183,639 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    10,000
  • Common Stock

    (indirect: 2023 GRAT)
    9,793
  • Common Stock

    (indirect: 2022 GRAT)
    4,048
  • Common Stock

    (indirect: 2024 GRAT)
    20,000
  • Common Stock

    (indirect: 2025 GRAT)
    20,000
  • Common Stock

    (indirect: By Trust)
    750
  • Common Stock

    (indirect: By Trust)
    230
  • Common Stock

    (indirect: By Trust)
    2,250
Footnotes (1)
  • [F1]On February 20, 2025, 20,000 shares were transferred from Direct Holdings to the 2025 GRAT account.

Issuer

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CIK 0001100682

Entity typeother

Related Parties

1
  • filerCIK 0001141722

Filing Metadata

Form type
4
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 4:41 PM ET
Size
10.3 KB